Mirapex
NDC Package 0597-0113-30

The code 0597-0113-30 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 30 tablet, extended release in 1 bottle, plastic of Mirapex ER, labeled by Boehringer Ingelheim Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Boehringer Ingelheim Pharmaceuticals, Inc. on February 22, 2010. The current certification is valid through June 20, 2024.

Pramipexole is used alone or with other medications to treat Parkinson's disease. It can improve your ability to move and decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move ("on-off syndrome"). This medication is also used to treat a certain medical condition (restless legs syndrome - RLS) that causes an unusual urge to move the legs. Symptoms usually occur at night along with uncomfortable/unpleasant feelings in the legs. This medication can decrease these symptoms and thereby improve sleep. Pramipexole is a dopamine agonist that works by helping to restore the balance of a certain natural substance (dopamine) in the brain.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00597011330. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.